These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30779366)

  • 21. Photodynamic therapy as an innovative treatment for malignant pleural mesothelioma.
    Friedberg JS
    Semin Thorac Cardiovasc Surg; 2009; 21(2):177-87. PubMed ID: 19822291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosimetry in pleural photodynamic therapy.
    Zhu TC
    J Natl Compr Canc Netw; 2012 Oct; 10 Suppl 2():S60-4. PubMed ID: 23055219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma.
    Villanova T; Gesmundo I; Audrito V; Vitale N; Silvagno F; Musuraca C; Righi L; Libener R; Riganti C; Bironzo P; Deaglio S; Papotti M; Cai R; Sha W; Ghigo E; Schally AV; Granata R
    Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2226-2231. PubMed ID: 30659154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro.
    Hoda MA; Pirker C; Dong Y; Schelch K; Heffeter P; Kryeziu K; van Schoonhoven S; Klikovits T; Laszlo V; Rozsas A; Ozsvar J; Klepetko W; Döme B; Grusch M; Hegedüs B; Berger W
    Mol Cancer Ther; 2016 Oct; 15(10):2357-2369. PubMed ID: 27512118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interstitial fluid pressure: A novel biomarker to monitor photo-induced drug uptake in tumor and normal tissues.
    Cavin S; Wang X; Zellweger M; Gonzalez M; Bensimon M; Wagnières G; Krueger T; Ris HB; Gronchi F; Perentes JY
    Lasers Surg Med; 2017 Oct; 49(8):773-780. PubMed ID: 28544068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PDT dose dosimetry for Photofrin-mediated pleural photodynamic therapy (pPDT).
    Ong YH; Kim MM; Finlay JC; Dimofte A; Singhal S; Glatstein E; Cengel KA; Zhu TC
    Phys Med Biol; 2017 Dec; 63(1):015031. PubMed ID: 29106380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells.
    Pattarozzi A; Carra E; Favoni RE; Würth R; Marubbi D; Filiberti RA; Mutti L; Florio T; Barbieri F; Daga A
    Stem Cell Res Ther; 2017 May; 8(1):119. PubMed ID: 28545562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-occurring Mutations of Tumor Suppressor Genes,
    Tranchant R; Quetel L; Tallet A; Meiller C; Renier A; de Koning L; de Reynies A; Le Pimpec-Barthes F; Zucman-Rossi J; Jaurand MC; Jean D
    Clin Cancer Res; 2017 Jun; 23(12):3191-3202. PubMed ID: 28003305
    [No Abstract]   [Full Text] [Related]  

  • 29. In Vitro and In Vivo Antitumor Activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma.
    Muscella A; Vetrugno C; Cossa LG; Antonaci G; De Nuccio F; De Pascali SA; Fanizzi FP; Marsigliante S
    PLoS One; 2016; 11(11):e0165154. PubMed ID: 27806086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trametinib plus 4-Methylumbelliferone Exhibits Antitumor Effects by ERK Blockade and CD44 Downregulation and Affects PD-1 and PD-L1 in Malignant Pleural Mesothelioma.
    Cho H; Matsumoto S; Fujita Y; Kuroda A; Menju T; Sonobe M; Kondo N; Torii I; Nakano T; Lara PN; Gandara DR; Date H; Hasegawa S
    J Thorac Oncol; 2017 Mar; 12(3):477-490. PubMed ID: 27867002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemo-manipulation of tumor blood vessels by a metal-based anticancer complex enhances antitumor therapy.
    Riedel T; Cavin S; van den Bergh H; Krueger T; Liaudet L; Ris HB; Dyson PJ; Perentes JY
    Sci Rep; 2018 Jul; 8(1):10263. PubMed ID: 29980753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of pleural malignancies by photo-induction combined to systemic chemotherapy: Proof of concept on rodent lung tumors and feasibility study on porcine chest cavities.
    Wang X; Gronchi F; Bensimon M; Mercier T; Decosterd LA; Wagnières G; Debefve E; Ris HB; Letovanec I; Peters S; Perentes JY
    Lasers Surg Med; 2015 Dec; 47(10):807-16. PubMed ID: 26415084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.
    Greillier L; Tounsi A; Berenguer-Daizé C; Dussault N; Delfino C; Benyahia Z; Cayol M; Mabrouk K; Garcia S; Martin PM; Barlesi F; Ouafik L
    J Thorac Oncol; 2016 Jan; 11(1):94-107. PubMed ID: 26762744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A preclinical model to investigate the role of surgically-induced inflammation in tumor responses to intraoperative photodynamic therapy.
    Davis RW; Papasavvas E; Klampatsa A; Putt M; Montaner LJ; Culligan MJ; McNulty S; Friedberg JS; Simone CB; Singhal S; Albelda SM; Cengel KA; Busch TM
    Lasers Surg Med; 2018 Jul; 50(5):440-450. PubMed ID: 29799130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia Inducible Factor-1α Inhibition in Von Hippel Lindau-mutant Malignant Pleural Mesothelioma Cells.
    Shukuya T; Oyanagi J; Serizawa M; Watanabe M; Yamamoto N; Koh Y
    Anticancer Res; 2020 Apr; 40(4):1867-1874. PubMed ID: 32234874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesothelioma.
    Xu D; Liang SQ; Yang H; Lüthi U; Riether C; Berezowska S; Marti TM; Hall SRR; Bruggmann R; Kocher GJ; Schmid RA; Peng RW
    Br J Cancer; 2018 Jul; 119(1):65-75. PubMed ID: 29921948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells.
    Zanellato I; Colangelo D; Osella D
    Curr Cancer Drug Targets; 2018; 18(8):816-828. PubMed ID: 28669341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase II trial of dovitinib in previously-treated advanced pleural mesothelioma: The Ontario Clinical Oncology Group.
    Laurie SA; Hao D; Leighl NB; Goffin J; Khomani A; Gupta A; Addison CL; Bane A; Seely J; Filion ML; Pond GR; Levine MN
    Lung Cancer; 2017 Feb; 104():65-69. PubMed ID: 28213002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts.
    Lam SK; Li YY; Xu S; Leung LL; U KP; Zheng YF; Cheng PN; Ho JC
    Respir Res; 2017 May; 18(1):80. PubMed ID: 28464918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant pleural mesothelioma: an update on diagnosis and treatment options.
    Kondola S; Manners D; Nowak AK
    Ther Adv Respir Dis; 2016 Jun; 10(3):275-88. PubMed ID: 26873306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.